Dyadic International, Inc. is a global biotechnology company focused on further improving and applying the proprietary C expression system to help drug developers and manufacturers bring biologic drugs to market faster, in greater volumes, at lower cost, and with new properties that will improve access and cost to patients and the healthcare system, but most importantly save lives.
Quote | Dyadic International Inc. (OTCMKTS:DYAI)
Last: | $ |
---|---|
Change Percent: | -3.17% |
Open: | $6.03 |
Close: | $5.80 |
High: | $6.10 |
Low: | $5.75 |
Volume: | 122,551 |
Last Trade Date Time: | 02/12/2020 04:55:12 pm |
News | Dyadic International Inc. (OTCMKTS:DYAI)
JUPITER, Fla., June 28, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI), announced today that they have entered into a development and commercialization partnership with Proliant Health and Biologicals (PHB), a leading supplier of purified proteins for ...
JUPITER, Fla., May 30, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and animal vaccines and therapeutics, as well a...
Message Board Posts | Dyadic International Inc. (OTCMKTS:DYAI)
Subject | By | Source | When |
---|---|---|---|
$DYAI where is the squeeze? | blue_skies | investorshub | 04/27/2023 7:53:41 PM |
Price now last up | natec22 | investorshub | 04/27/2023 11:11:40 AM |
$DYAI Price trading up | blue_skies | investorshub | 04/27/2023 8:33:31 AM |
best news of the day | blue_skies | investorshub | 04/27/2023 7:59:27 AM |
Price now last up | blue_skies | investorshub | 04/26/2023 9:11:17 PM |
News, Short Squeeze, Breakout and More Instantly...
Dyadic International Inc. Company Name:
DYAI Stock Symbol:
OTCMKTS Market:
Dyadic International Inc. Website:
JUPITER, Fla., June 28, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI), announced today that they have entered into a development and commercialization partnership with Proliant Health and Biologicals (PHB), a leading supplier of purified proteins for ...
JUPITER, Fla., May 30, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and animal vaccines and therapeutics, as well a...
Human Health Sector Final Clinical Study Report has been issued for the First-In-Human Phase 1 clinical trial demonstrating safety and antibody response for DYAI-100, a recombinant protein receptor binding domain booster vaccine candidate for protection against C...